CONMED Corporation (CNMD) Sets 52-Week High on May, 16

May 16, 2018 - By Alice Reed

CONMED Corporation (NASDAQ:CNMD) Corporate Logo

Big Money Sentiment decreased to 1.3 in Q4 2017. It has change of 0.04, from 2017Q3’s 1.34. The ratio worsened due to CONMED Corporation positioning: 7 sold and 46 reduced. 25 funds acquired stakes and 44 increased stakes. Investors holded 27.14 million in 2017Q3 but now own 26.91 million shares or 0.87% less.
Pnc Financial Serv reported 671 shs. Morgan Stanley holds 0% in CONMED Corporation (NASDAQ:CNMD) or 131,480 shs. Cna Corporation, Illinois-based fund reported 5,503 shs. Koch has invested 0.04% in CONMED Corporation (NASDAQ:CNMD). Texas-based Westwood Group Inc has invested 0.14% in CONMED Corporation (NASDAQ:CNMD). Group Inc One Trading L P invested 0% in CONMED Corporation (NASDAQ:CNMD). State Street Corp accumulated 892,466 shs. Legal General Group Incorporated Public Limited Com owns 52,005 shs for 0% of their capital. Gamco Invsts Et Al holds 88,400 shs or 0.03% of its capital. California Pub Employees Retirement Sys has invested 0.01% in CONMED Corporation (NASDAQ:CNMD). Jpmorgan Chase & Company reported 0% of its capital in CONMED Corporation (NASDAQ:CNMD). Tiaa Cref Mgmt Ltd Co reported 68,223 shs. Voya Invest Mngmt Limited Liability Company has 0% invested in CONMED Corporation (NASDAQ:CNMD) for 12,919 shs. State Of Alaska Department Of Revenue invested 0.01% of its capital in CONMED Corporation (NASDAQ:CNMD). Wells Fargo & Mn invested 0% in CONMED Corporation (NASDAQ:CNMD).

CONMED Corporation had 10 insider sales and 1 insider purchase since January 3, 2018. This’s net activity of $4.11 million. Shares for $241,574 were sold by Berge Terence M. Shares for $7,996 were bought by Farkas Charles on Wednesday, January 3. Another trade for 1,962 shs valued at $118,211 was made by POMILIO LUKE A on Monday, February 12. On Friday, April 27 $286,497 worth of CONMED Corporation (NASDAQ:CNMD) was sold by Folkert Nathan. JONAS DANIEL sold 2,000 shs worth $131,160.

The company CONMED Corporation (NASDAQ:CNMD) touched 52 week high with $72.33 PT or 5.00 % above today’s $68.89 price per share. It was published on May, 16 according to Barchart.com. CONMED Corporation (NASDAQ:CNMD) has $1.93 billion market cap. At our $72.33 PT, the company worth will be $96.60M more.

The stock increased 0.98% or $0.67 during the last trading session, reaching $68.89.Currently CONMED Corporation is uptrending after 46.44% change in last May 16, 2017. CNMD has 78,152 shares volume. CNMD outperformed the S&P 500 by 34.89%.

On July, 25 CONMED Corporation (NASDAQ:CNMD)’s earnings release is anticipated by WallStreet, Faxor reports. Analysts have expectation on stock’s EPS of $0.45. That’s up 9.76 % from last year’s $0.41 EPS. If reported the P/E will be 38.27 with $12.62 million profit. Wall Street forecasts -15.09 % negative EPS growth as of July, 25.

CONMED Corporation (NASDAQ:CNMD) Ratings Coverage

Total analysts of 2 have positions in Conmed Corp (NASDAQ:CNMD) as follows: 1 rated it a “Buy”, 0 with “Sell” and 1 with “Hold”. The positive are 50%. The firm has $7300 highest while $54.0 is the lowest target price. The average target $63.50 is -7.82% below the last ($68.89) price. Since November 17, 2017 according to StockzIntelligence Inc Conmed Corp has 4 analyst reports. The stock rating was maintained by Needham with “Buy” on Thursday, April 26. The stock rating was maintained by Piper Jaffray with “Hold” on Thursday, February 1. On Thursday, February 1 the stock has “Buy” rating by Needham. On Friday, November 17 the stock of CONMED Corporation (NASDAQ:CNMD) earned “Buy” rating by Needham.

Another two news for CONMED Corporation (NASDAQ:CNMD) were recently announced by: Benzinga.com on May 09, 2018 with title “Benzinga’s Daily Biotech Pulse: Transenterix Rises, Mylan Earnings, Deutsche Bank Conference Underway”. The other Globenewswire.com‘s article was titled “Market Trends Toward New Normal in Cohen & Steers, Achaogen, Ares Commercial Real Estate, CONMED, Marcus …” and announced on May 02, 2018.

CONMED Corporation, a medical technology company, develops, makes, and sells surgical devices and related equipment for minimally invasive procedures in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.The firm is worth $1.93 billion. The firm offers sports medicine products, such as powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, metal and bio absorbable implants, and related disposable products and fluid management systems; powered surgical instruments for use in large and small bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; and sports biologics and tissues.34.97 is the P/E ratio. It also provides electrosurgical generators, hand pieces, smoke management systems, and accessories for surgical needs; and endomechanical instrumentation products that offer various instruments comprising trocars, suction irrigation devices, graspers, scissors, and dissectors used in the minimally invasive laparoscopic and gynecological surgery, as well as an uterine manipulator for use in the laparoscopic hysterectomies and other gynecologic laparoscopic procedures.

CONMED Corporation (NASDAQ:CNMD) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: